Phenotypic Expression of Hodgkin's and Reed-Sternberg Cells in Hodgkin's Disease
Overview
Affiliations
The phenotypic expression of Hodgkin's and Reed-Sternberg (H-RS) cells was determined by analysis with a panel of monoclonal antibodies and peanut agglutinin (PNA) by an immunohistochemical technique. Seven antibodies, including T200, anti-HLA-DR, anti-Leu 10, A1G3, anti-Tac, OKT9, and anti-Leu M1, were found to react with a great majority of H-RS cells. In some cases, H-RS cells also bound PNA. Other antibodies, including those highly specific for T cells (eg, Lyt 3) and B cells (eg, B1, anti-Leu 14) were consistently negative. The results argue against the derivation of H-RS cells from T or B lymphocytes. The H-RS cells were also negatively stained with antibodies which react with monocytes (OKM1, Mo-2, 63D-3), follicular dendritic cells (DRC-1), and natural killer/killer cells (Leu 7, Leu 11a, B73.1). The presence of Leu M1 and Tac in H-RS cells is of interest. Anti-Leu M1 positivity was seen in all 20 of Hodgkin's disease (HD) cases tested and should provide a very useful reagent for differential diagnosis of HD from other reactive and neoplastic conditions. Tac normally is present only on activated T cells. The presence of Tac in H-RS cells may reflect expression of T-cell growth factor receptor or a closely related protein during a stage of neoplastic transformation. Although the nature of the neoplastic cell of HD cannot be determined by these studies, they are consistent with an origin from interdigitating reticulum cells. Both H-RS cells and interdigitating reticulum cells have a similar antigenic phenotype (Leu M1+, T200+, HLA-DR+, Leu 10+, A1G3+, and OKT9+) and a similar pattern of lysosomal enzyme activity.
Santisteban-Espejo A, Bernal-Florindo I, Perez-Requena J, Atienza-Cuevas L, Moran-Sanchez J, Fernandez-Valle M Diagnostics (Basel). 2022; 12(4).
PMID: 35454013 PMC: 9027849. DOI: 10.3390/diagnostics12040963.
Janik J, Morris J, OMahony D, Pittaluga S, Jaffe E, Redon C Proc Natl Acad Sci U S A. 2015; 112(42):13045-50.
PMID: 26438866 PMC: 4620907. DOI: 10.1073/pnas.1516107112.
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.
Jaffe E, Lee Harris N, Stein H, Isaacson P Blood. 2008; 112(12):4384-99.
PMID: 19029456 PMC: 2954680. DOI: 10.1182/blood-2008-07-077982.
Receptor-directed therapy of T-cell leukemias and lymphomas.
Morris J, Waldmann T, Janik J J Immunotoxicol. 2008; 5(2):235-48.
PMID: 18569395 PMC: 7243878. DOI: 10.1080/15476910802129661.
Biological significance of soluble IL-2 receptor.
Caruso C, Candore G, Cigna D, Colucci A, Modica M Mediators Inflamm. 1993; 2(1):3-21.
PMID: 18475497 PMC: 2365387. DOI: 10.1155/S0962935193000018.